Clincosm LogoSign in Get a demo

nsclc, stage i

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC, Stage I Trial in Xi'an (Segmentectomy, Lobectomy)

Enrolling by invitation
  • NSCLC, Stage I
  • Segmentectomy
  • Lobectomy
  • Xi'an, Shannxi, China
    The Second Affiliated Hospital of Air Force Medical University U
Sep 7, 2023

NSCLC, Stage I Trial in Tianjin (Osimertinib)

Recruiting
  • NSCLC, Stage I
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute & Hospital
Jan 6, 2023

NSCLC, Stage I Trial in United States (Pembrolizumab)

Recruiting
  • NSCLC, Stage I
  • Tampa, Florida
  • +10 more
Dec 12, 2022

NSCLC, Stage I Trial (Tislelizumab monotherapy)

Not yet recruiting
  • NSCLC, Stage I
  • Tislelizumab monotherapy
  • (no location specified)
Mar 9, 2022

Adjuvant Therapy in Early Stage NSCLC With EGFR

Recruiting
  • NSCLC, Stage I
  • +2 more
  • Surgeries
  • Peking, Beijing, China
  • +50 more
Mar 31, 2021

NSCLC, Stage I Trial in Finland, Norway, Sweden (Durvalumab)

Recruiting
  • NSCLC, Stage I
  • Helsinki, Finland
  • +14 more
Mar 3, 2021

The Role of Microbiota on the Development of Lung Cancer

Unknown status
  • NSCLC, Stage I
  • +4 more
  • without intervention type
  • Wuhan, Hubei, China
    Union hospital
May 31, 2019

NSCLC, Stage I Trial (SABR, SABR + pembrolizumab)

Unknown status
  • NSCLC, Stage I
  • SABR
  • SABR + pembrolizumab
  • (no location specified)
Feb 20, 2018